Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) was the recipient of a large drop in short interest in September. As of September 30th, there was short interest totalling 7,740,000 shares, a drop of 17.7% from the September 15th total of 9,400,000 shares. Approximately 6.5% of the…
